Tag: Cancer: Lung
Osimertinib Tops Standard EGFR-TKI for EGFR+ NSCLC
Significantly longer median progression-free survival for osimertinib in previously untreated NSCLC
Erlotinib Overdose Tied to Conjunctivitis
Findings in case study of man being treated for non-small-cell lung cancer
The American College of Chest Physicians, Oct. 28-Nov. 1
The 83rd Annual Meeting of the American College of Chest Physicians The annual meeting of the American College of Chest Physicians...
The American College of Chest Physicians, Oct. 28-Nov. 1
The 83rd Annual Meeting of the American College of Chest Physicians The annual meeting of the American College of Chest Physicians...
Treatment for Stage I NSCLC Patients Up From 2000 to 2010
Improved survival for non-small-cell lung cancer patients, driven by better survival in treated patients
2003 to 2014 Saw Drop in Urinary Arsenic in Public Water Users
Reduction occurred after implementation of EPA's maximum contaminant level for arsenic
Uninsurance Down by One-Third for Cancer Diagnoses in 2014
Significant decreases in uninsurance seen across all stages and sites assessed in first year of ACA
Primary, Pulmonary Providers Endorse Lung CA Screening
Key barriers to LCS include inadequate time and staffing, patients having too many illnesses
Checkpoint Inhibitors No Less Safe With Radiation
Combination does not increase immune-related adverse events in metastatic lung cancer patients
Accurate Lung Cancer Staging Depends on Quality Nodal Exam
Difference in exam thoroughness may account for large regional differences in survival
